GUIDED THERAPEUTICS, INC. (GTHP) Net margin 2017–2025
GUIDED THERAPEUTICS, INC. (GTHP) net profit margin by fiscal year — reported net income divided by reported revenue.
-416.7%FY2025 · since FY2017: -4383.6% → -416.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -416.7% | +34111.9 pp |
| FY2024 | -34528.6% | -30968.4 pp |
| FY2023 | -3560.2% | +29832.1 pp |
| FY2022 | -33392.3% | -30836.8 pp |
| FY2021 | -2555.6% | -2282.0 pp |
| FY2020 | -273.5% | +5062.6 pp |
| FY2019 | -5336.1% | -7118.6 pp |
| FY2018 | 1782.5% | +6166.1 pp |
| FY2017 | -4383.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GTHP financial trends
GTHP RevenueGTHP Net incomeGTHP Gross profitGTHP Gross marginGTHP Operating incomeGTHP Operating marginGTHP Operating cash flowGTHP Free cash flowGTHP Capital expendituresGTHP Return on equityGTHP Stock buybacksGTHP Dividends paidGTHP Total assetsGTHP Total liabilitiesGTHP Shareholders’ equityGTHP overview →